Company Name | Enterprise Value |
---|---|
Toyota Motor Corporation | 79935851261357 |
Honda Motor Co., Ltd. | 32916489228993 |
Sony Group Corporation | 18269948305195 |
HDFC Bank Limited | 16084979636740 |
Takeda Pharmaceutical Company Limited | 8501221588723 |
In pursuit of knowledge
In 2024, the landscape of global enterprise value is dominated by a select few giants. Leading the pack is Toyota Motor Corporation, with an impressive enterprise value of approximately $79.94 trillion. This figure underscores Toyota's unparalleled influence in the automotive sector, accounting for nearly 26% of the combined value of the top five companies.
Honda Motor Co., Ltd. follows, holding a significant 33% of Toyota's value, showcasing its robust market presence. Sony Group Corporation, a stalwart in electronics and entertainment, commands an enterprise value of around $18.27 trillion, reflecting its diversified portfolio and innovative prowess.
HDFC Bank Limited, a major player in the financial sector, and Takeda Pharmaceutical Company Limited, a leader in healthcare, round out the top five with values of $16.09 trillion and $8.50 trillion, respectively. Together, these companies illustrate the diverse sectors driving economic growth and innovation in 2024.
These insights provide a snapshot of the economic powerhouses shaping our world in 2024, each contributing uniquely to the global market landscape.
5 Year Trend in Average Market Capitalization for AbbVie
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
Average Market Capitalization of Abbvie Annually
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Pharma Companies
5 Year Trend in Average Market Capitalization for AbbVie
5 Year Trend in Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Number of Employees for Top 10 Healthcare Companies
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters